PFKFB3 As a Multifaceted Driver and Therapeutic Target in Castration-Resistant Prostate Cancer

Researchers showed that PFKFB3, an essential regulator of glycolytic metabolism, is significantly upregulated in prostate cancer tissues and CRPC cell lines, where it plays a pivotal role in driving CRPC progression.